Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
about
Molecular action of methotrexate in inflammatory diseasesEstablishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cellsChronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recoveringMethotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?Combination therapy for autoimmune diseases: the rheumatoid arthritis model.Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in respondersAnti-Inflammatory Activity of a Polymeric Proanthocyanidin from Serjania schiedeana.Administration of PDE4 inhibitors suppressed the pannus-like inflammation by inhibition of cytokine production by macrophages and synovial fibroblast proliferation.New therapeutic options in uveitis.Mechanisms underlying methotrexate-induced pulmonary toxicity.Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937.Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritisMethotrexate use in systemic lupus erythematosus.Use of methotrexate in the management of sight-threatening uveitis.
P2860
Q24534771-A2459665-1FF3-4E52-B269-C212AF9C8F5CQ28360538-AC55E32E-1654-4F71-A938-EEAB33D5255DQ30415505-ED101720-F953-41E3-BCA7-A51FF07AF680Q33869850-4FAD39EE-3EED-4610-844B-7C90C66ED90AQ34309751-D7613D59-3DCA-426C-8198-54B6CCE22AD9Q35638652-C83CCA0E-2AE5-4276-AA75-75A55DA9FAA2Q36394198-49B2FF48-DB3A-4CE5-A202-053FB04DC804Q36445628-EDBBD750-7146-4B2E-B1A2-B68D3604DE9CQ36888392-DFCD2000-17D7-4C3F-9211-565E36D01BD4Q37524010-3250B7DA-E036-4C22-A803-0EA4CF96DD67Q37728232-B63D895C-AD93-4EF0-848C-138F31B10B7CQ38649371-7B43AEDE-ABD3-4D8E-8D42-BF38D17D5D97Q41208644-E5F97314-5B33-4E00-BAE6-5E62DD95C598Q41491179-9B1B9995-B9C7-462E-86F2-DCD67F78F54CQ43550379-3767FE93-AD8F-4FF2-A04B-026CFC8BD737
P2860
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@en
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@nl
type
label
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@en
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@nl
prefLabel
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@en
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@nl
P356
P1476
Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.
@en
P2093
P304
P356
10.1002/ANR.1780320404
P577
1989-04-01T00:00:00Z